We prepare, maintain and promote access to systematic reviews of interventions to treat or prevent eye diseases or visual impairment. We also do systematic reviews of the accuracy of diagnostic tests for common ocular diseases or conditions.
Links to our Reviews
| Status | Stage |
|---|---|
- 5-Fluorouracil for glaucoma surgery
- Ab interno supraciliary microstent surgery for open-angle glaucoma
- Ab interno trabecular bypass surgery with iStent for open-angle glaucoma
- Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma
- Ab interno trabecular bypass surgery with Trabectome for open-angle glaucoma
- Accommodative intraocular lens versus standard monofocal intraocular lens implantation in cataract surgery
- Acupuncture for acute hordeolum
- Acupuncture for glaucoma
- Acupuncture for slowing the progression of myopia in children and adolescents
- Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
- Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure
- Adjustable versus non-adjustable sutures for strabismus
- Adverse events associated with minimally invasive glaucoma surgeries (MIGS) including bleb-forming microstent surgeries
- Aflibercept for neovascular age-related macular degeneration
- Amniotic membrane transplantation for acute ocular burns
- Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis
- Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration
- Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
- Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
- Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
- Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
- Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
- Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
- Anti-vascular endothelial growth factor for neovascular glaucoma
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
- Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
- Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration
- Antibiotic prophylaxis for corneal abrasion
- Antibiotics for trachoma
- Antibiotics versus no treatment for toxoplasma retinochoroiditis
- Antibiotics versus placebo for acute bacterial conjunctivitis
- Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
- Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
- Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
- Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
- Approaches for delivery of refractive and optical care services in community and primary care settings
- Aqueous shunts for glaucoma
- Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma
- Artificial corneas versus donor corneas for repeat corneal transplants
- Artificial intelligence for detecting keratoconus
- Artificial intelligence for diagnosing exudative age-related macular degeneration
- Aspirin as adjunctive treatment for giant cell arteritis
- Assistive technology for children and young people with low vision
- Autologous serum eye drops for dry eye
- Beta radiation for glaucoma surgery
- Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years
- Blood pressure control for diabetic retinopathy
- Blue-light filtering intraocular lenses (IOLs) for protecting macular health
- Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults
- Botulinum toxin for the treatment of strabismus
- Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma
- Community screening for visual impairment in older people
- Complement inhibitors for age-related macular degeneration
- Conjunctival autograft for pterygium
- Conventional occlusion versus pharmacologic penalization for amblyopia
- Corneal collagen cross-linking for bacterial infectious keratitis
- Corneal collagen cross-linking for treating keratoconus
- Corticosteroid implants for chronic non-infectious uveitis
- Corticosteroids as adjuvant therapy for ocular toxoplasmosis
- Corticosteroids for periorbital and orbital cellulitis
- Corticosteroids for treating optic neuritis
- Cyclodestructive procedures for non-refractory glaucoma
- Cyclodestructive procedures for refractory glaucoma
- Day care versus in-patient surgery for age-related cataract
- Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus
- Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure
- Device-modified trabeculectomy for glaucoma
- Different lasers and techniques for proliferative diabetic retinopathy
- Different-sized incisions for phacoemulsification in age-related cataract
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Early vitrectomy for exogenous endophthalmitis following surgery
- Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction
- Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure
- Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy
- Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment
- Environmental sanitary interventions for preventing active trachoma
- Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia
- Face washing promotion for preventing active trachoma
- Face-down positioning or posturing after macular hole surgery
- Face-down positioning or posturing after pars plana vitrectomy for macula-involving rhegmatogenous retinal detachments
- Fenofibrate for diabetic retinopathy
- Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery
- Focal laser treatment in addition to chemotherapy for retinoblastoma
- Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma
- Ginkgo biloba extract for age-related macular degeneration
- Glaucoma drainage devices versus trabeculectomy for lowering intraocular pressure in people of West African origin
- Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis
- Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts
- Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty
- Implantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degeneration
- Integrated versus non-integrated orbital implants for treating anophthalmic sockets
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction
- Interventions for acute non-arteritic central retinal artery occlusion
- Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Interventions for chronic blepharitis
- Interventions for convergence insufficiency: a network meta-analysis
- Interventions for dissociated vertical deviation
- Interventions for eye movement disorders due to acquired brain injury
- Interventions for idiopathic intracranial hypertension
- Interventions for improving adherence to amblyopia treatments in children
- Interventions for improving adherence to ocular hypotensive therapy
- Interventions for infantile esotropia
- Interventions for intermittent exotropia
- Interventions for involutional lower lid entropion
- Interventions for late trabeculectomy bleb leak
- Interventions for Mooren's ulcer
- Interventions for orbital lymphangioma
- Interventions for preventing ophthalmia neonatorum
- Interventions for preventing posterior capsule opacification
- Interventions for prevention of giant retinal tear in the fellow eye
- Interventions for recurrent corneal erosions
- Interventions for strabismic amblyopia
- Interventions for the management of CMV-associated anterior segment inflammation
- Interventions for trachoma trichiasis
- Interventions for unilateral and bilateral refractive amblyopia
- Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries
- Interventions to increase attendance for diabetic retinopathy screening
- Interventions to increase time spent outdoors for preventing incidence and progression of myopia in children
- Interventions to slow progression of myopia in children
- Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery
- Intraoperative Mitomycin C for glaucoma surgery
- Intrastromal corneal ring segments for treating keratoconus
- Intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma
- Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
- Intravitreal steroids for macular edema in diabetes
- Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion
- Iridotomy to slow progression of visual field loss in angle-closure glaucoma
- Ivermectin for onchocercal eye disease (river blindness)
- Laser peripheral iridoplasty for chronic angle closure
- Laser photocoagulation for choroidal neovascularisation in pathologic myopia
- Laser photocoagulation for neovascular age-related macular degeneration
- Laser photocoagulation for proliferative diabetic retinopathy
- Laser trabeculoplasty for open-angle glaucoma and ocular hypertension
- Laser treatment of drusen to prevent progression to advanced age-related macular degeneration
- Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
- Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia
- Laser-assisted in-situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism
- Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia
- Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia
- Lens extraction for chronic angle-closure glaucoma
- Lens extraction versus laser peripheral iridotomy for acute primary angle closure
- LipiFlow for the treatment of dry eye disease
- Low vision rehabilitation for better quality of life in visually impaired adults
- Lubricating drops for contact lens discomfort in adults
- Macular grid laser photocoagulation for branch retinal vein occlusion
- Macular translocation for neovascular age-related macular degeneration
- Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract
- Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for age-related cataract
- Medical and surgical interventions for neurotrophic keratopathy
- Medical interventions for acanthamoeba keratitis
- Medical interventions for fungal keratitis
- Medical interventions for non-arteritic anterior ischaemic optic neuropathy
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Medical interventions for traumatic hyphema
- Medical interventions for treating primary angle-closure glaucoma
- Medical versus surgical interventions for open angle glaucoma
- Minimally invasive trabecular meshwork surgery for open-angle glaucoma
- Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery
- Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma
- Monotherapy laser photocoagulation for diabetic macular oedema
- Multifaceted behavioral interventions to improve treatment adherence of glaucoma
- Multifocal versus monofocal intraocular lenses after cataract extraction
- N-acetylcarnosine (NAC) drops for age-related cataract
- Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters
- Needling for encapsulated trabeculectomy filtering blebs
- Neuroprotection for treatment of glaucoma in adults
- Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults
- Non-contact tests for identifying people at risk of primary angle closure glaucoma
- Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma
- Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery
- Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery
- Non-surgical interventions for acute internal hordeolum
- Occlusion for stimulus deprivation amblyopia
- Ocriplasmin for symptomatic vitreomacular adhesion
- Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration
- Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease
- Optic nerve head and fibre layer imaging for diagnosing glaucoma
- Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
- Optical coherence tomography angiography for monitoring the treatment of neovascular age-related macular degeneration
- Optical reading aids for children and young people with low vision
- Oral antibiotics for chronic blepharitis
- Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts
- Orbital radiotherapy for adult thyroid eye disease
- Orientation and mobility training for adults with low vision
- Over the counter (OTC) artificial tear drops for dry eye syndrome
- Pain control during panretinal photocoagulation for diabetic retinopathy
- Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear
- Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments
- Pars plana vitrectomy with internal limiting membrane flap versus pars plana vitrectomy with conventional internal limiting membrane peeling for large macular hole
- Patching for corneal abrasion
- Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery
- Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
- Peripheral iridotomy for pigmentary glaucoma
- Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract
- Pharmacologic interventions for mydriasis in cataract surgery
- Photobiomodulation for non-exudative age-related macular degeneration
- Photodynamic therapy for neovascular age-related macular degeneration
- Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction
- Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments
- Probing for congenital nasolacrimal duct obstruction
- Prognostic factors for predicting progression of open angle glaucoma in adults
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery
- Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery
- Punctal occlusion for dry eye syndrome
- Radiotherapy for neovascular age-related macular degeneration
- Reading aids for adults with low vision
- Real-world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
- Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
- Rituximab for thyroid-associated ophthalmopathy
- Routine preoperative medical testing for cataract surgery
- Screening for prevention of optic nerve damage due to chronic open angle glaucoma
- Silicone hydrogel versus hydrogel soft contact lenses for differences in patient-reported eye comfort and safety
- Single herbal medicine for diabetic retinopathy
- Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children
- Statins for age-related macular degeneration
- Steroids for traumatic optic neuropathy
- Strabismus surgery before versus after completion of amblyopia therapy in children
- Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma
- Sublingual immunotherapy for treating allergic conjunctivitis
- Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration
- Surgery for cataracts in people with age-related macular degeneration
- Surgery for idiopathic epiretinal membrane
- Surgery for nonarteritic anterior ischemic optic neuropathy
- Surgery for postvitrectomy cataract
- Surgery for traumatic optic neuropathy
- Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration
- Surgical interventions for age-related cataract
- Surgical interventions for bilateral congenital cataract in children aged two years and under
- Surgical interventions for infantile nystagmus syndrome
- Surgical interventions for lamellar macular holes
- Surgical interventions for primary congenital glaucoma
- Surgical interventions for vertical strabismus in superior oblique palsy
- Surgical orbital decompression for thyroid eye disease
- Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
- Systemic treatment for blepharokeratoconjunctivitis in children
- Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy
- Tea tree oil for Demodex blepharitis
- Telerehabilitation for people with low vision
- Tests for detecting strabismus in children aged 1 to 6 years in the community
- Tocilizumab for giant cell arteritis
- Tocilizumab for thyroid eye disease
- Topical antibiotics for treating bacterial keratitis: a network meta-analysis
- Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis
- Topical corticosteroids as adjunctive therapy for bacterial keratitis
- Topical corticosteroids for dry eye
- Topical cyclosporine A therapy for dry eye syndrome
- Topical cyclosporine for atopic keratoconjunctivitis
- Topical immunosuppressants for blepharitis in adults
- Topical medication instillation techniques for glaucoma
- Topical mydriatics as adjunctive therapy for traumatic iridocyclitis
- Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema
- Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions
- Topical ophthalmic anesthetics for corneal abrasions
- Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
- Topical treatments for blepharokeratoconjunctivitis in children
- Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification
- Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus
- Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
- Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia
- Trifocal versus extended depth of focus (EDOF) intraocular lenses after cataract extraction
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis
- Types of intraocular lenses for cataract surgery in eyes with uveitis
- Types of materials for frontalis sling surgery for congenital ptosis
- Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
- Virtual reality training for cataract surgery operating performance in ophthalmology trainees
- Vision screening for amblyopia in childhood
- Vision screening for correctable visual acuity deficits in school-age children and adolescents
- Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration
- Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
- Vitrectomy for idiopathic macular hole
- Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH)
- Wavefront excimer laser refractive surgery for adults with refractive errors
- Educational interventions for preventing eye injuries
- Interventions to slow the progression of short-sightedness in children
- Cataract (32)
- Accommodative intraocular lens versus standard monofocal intraocular lens implantation in cataract surgery
- Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery
- Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract
- Virtual reality training for cataract surgery operating performance in ophthalmology trainees
- Surgery for cataracts in people with age-related macular degeneration
- Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma
- Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract
- Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for age-related cataract
- Types of intraocular lenses for cataract surgery in eyes with uveitis
- Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract
- Different-sized incisions for phacoemulsification in age-related cataract
- Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery
- Interventions for preventing posterior capsule opacification
- Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries
- Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
- Multifocal versus monofocal intraocular lenses after cataract extraction
- N-acetylcarnosine (NAC) drops for age-related cataract
- Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery
- Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery
- Routine preoperative medical testing for cataract surgery
- Day care versus in-patient surgery for age-related cataract
- Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts
- Surgery for postvitrectomy cataract
- Surgical interventions for age-related cataract
- Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
- Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification
- Trifocal versus extended depth of focus (EDOF) intraocular lenses after cataract extraction
- Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia
- Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy
- Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery
- Pharmacologic interventions for mydriasis in cataract surgery
- Surgical interventions for bilateral congenital cataract in children aged two years and under
- Eye cancer [See also Cochrane Cancer Network] (3)
- Eye infections (14)
- After intraocular procedure (3)
- Bacterial (4)
- Other (4)
- Viral (3)
- Eye injuries (8)
- Amniotic membrane transplantation for acute ocular burns
- Antibiotic prophylaxis for corneal abrasion
- Educational interventions for preventing eye injuries
- Patching for corneal abrasion
- Medical interventions for traumatic hyphema
- Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions
- Topical mydriatics as adjunctive therapy for traumatic iridocyclitis
- Topical ophthalmic anesthetics for corneal abrasions
- Eye movement disorders (15)
- Adjustable versus non-adjustable sutures for strabismus
- Botulinum toxin for the treatment of strabismus
- Interventions for infantile esotropia
- Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children
- Interventions for convergence insufficiency: a network meta-analysis
- Interventions for eye movement disorders due to acquired brain injury
- Strabismus surgery before versus after completion of amblyopia therapy in children
- Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery
- Surgical interventions for vertical strabismus in superior oblique palsy
- Tests for detecting strabismus in children aged 1 to 6 years in the community
- Interventions for dissociated vertical deviation
- Interventions for unilateral and bilateral refractive amblyopia
- Interventions for strabismic amblyopia
- Surgical interventions for infantile nystagmus syndrome
- Interventions for intermittent exotropia
- Glaucoma (47)
- 5-Fluorouracil for glaucoma surgery
- Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma
- Acupuncture for glaucoma
- Adverse events associated with minimally invasive glaucoma surgeries (MIGS) including bleb-forming microstent surgeries
- Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
- Anti-vascular endothelial growth factor for neovascular glaucoma
- Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma
- Aqueous shunts for glaucoma
- Beta radiation for glaucoma surgery
- Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma
- Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma
- Device-modified trabeculectomy for glaucoma
- Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma
- Ab interno supraciliary microstent surgery for open-angle glaucoma
- Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure
- Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma
- Glaucoma drainage devices versus trabeculectomy for lowering intraocular pressure in people of West African origin
- Non-contact tests for identifying people at risk of primary angle closure glaucoma
- Interventions for improving adherence to ocular hypotensive therapy
- Interventions for late trabeculectomy bleb leak
- Iridotomy to slow progression of visual field loss in angle-closure glaucoma
- Ab interno trabecular bypass surgery with iStent for open-angle glaucoma
- Cyclodestructive procedures for non-refractory glaucoma
- Cyclodestructive procedures for refractory glaucoma
- Laser trabeculoplasty for open-angle glaucoma and ocular hypertension
- Lens extraction versus laser peripheral iridotomy for acute primary angle closure
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Medical interventions for treating primary angle-closure glaucoma
- Medical versus surgical interventions for open angle glaucoma
- Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
- Minimally invasive trabecular meshwork surgery for open-angle glaucoma
- Intraoperative Mitomycin C for glaucoma surgery
- Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery
- Needling for encapsulated trabeculectomy filtering blebs
- Neuroprotection for treatment of glaucoma in adults
- Peripheral iridotomy for pigmentary glaucoma
- Prognostic factors for predicting progression of open angle glaucoma in adults
- Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
- Screening for prevention of optic nerve damage due to chronic open angle glaucoma
- Optic nerve head and fibre layer imaging for diagnosing glaucoma
- Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
- Topical medication instillation techniques for glaucoma
- Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy
- Surgical interventions for primary congenital glaucoma
- Laser peripheral iridoplasty for chronic angle closure
- Lens extraction for chronic angle-closure glaucoma
- Ab interno trabecular bypass surgery with Trabectome for open-angle glaucoma
- Low vision (7)
- Assistive technology for children and young people with low vision
- Community screening for visual impairment in older people
- Low vision rehabilitation for better quality of life in visually impaired adults
- Optical reading aids for children and young people with low vision
- Orientation and mobility training for adults with low vision
- Reading aids for adults with low vision
- Telerehabilitation for people with low vision
- Neglected tropical diseases (6)
- Antibiotics for trachoma
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Environmental sanitary interventions for preventing active trachoma
- Face washing promotion for preventing active trachoma
- Interventions for trachoma trichiasis
- Ivermectin for onchocercal eye disease (river blindness)
- Optic nerve disease (5)
- Organisation of eye health care (5)
- Community screening for visual impairment in older people
- Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment
- Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries
- Vision screening for correctable visual acuity deficits in school-age children and adolescents
- Vision screening for amblyopia in childhood
- Other eye and vision conditions (16)
- Aspirin as adjunctive treatment for giant cell arteritis
- Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis
- Integrated versus non-integrated orbital implants for treating anophthalmic sockets
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction
- Interventions for idiopathic intracranial hypertension
- Strabismus surgery before versus after completion of amblyopia therapy in children
- Orbital radiotherapy for adult thyroid eye disease
- Surgical orbital decompression for thyroid eye disease
- Tocilizumab for thyroid eye disease
- Occlusion for stimulus deprivation amblyopia
- Interventions for strabismic amblyopia
- Conventional occlusion versus pharmacologic penalization for amblyopia
- Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years
- Vision screening for amblyopia in childhood
- Rituximab for thyroid-associated ophthalmopathy
- Tocilizumab for giant cell arteritis
- Outer eye (47)
- Blocked tear duct (3)
- Conjunctiva (8)
- Sublingual immunotherapy for treating allergic conjunctivitis
- Systemic treatment for blepharokeratoconjunctivitis in children
- Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis
- Topical treatments for blepharokeratoconjunctivitis in children
- Topical cyclosporine for atopic keratoconjunctivitis
- Antibiotics versus placebo for acute bacterial conjunctivitis
- Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
- Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years
- Cornea (20)
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
- Artificial corneas versus donor corneas for repeat corneal transplants
- Corneal collagen cross-linking for bacterial infectious keratitis
- Corneal collagen cross-linking for treating keratoconus
- Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus
- Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy
- Patching for corneal abrasion
- Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery
- Artificial intelligence for detecting keratoconus
- Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty
- Interventions for Mooren's ulcer
- Intrastromal corneal ring segments for treating keratoconus
- Medical interventions for acanthamoeba keratitis
- Medical interventions for fungal keratitis
- Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts
- Interventions for recurrent corneal erosions
- Conjunctival autograft for pterygium
- Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions
- Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure
- Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus
- Dry eye (7)
- Topical cyclosporine A therapy for dry eye syndrome
- Over the counter (OTC) artificial tear drops for dry eye syndrome
- Autologous serum eye drops for dry eye
- LipiFlow for the treatment of dry eye disease
- Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease
- Punctal occlusion for dry eye syndrome
- Topical corticosteroids for dry eye
- Eyelid (8)
- Acupuncture for acute hordeolum
- Non-surgical interventions for acute internal hordeolum
- Interventions for chronic blepharitis
- Interventions for involutional lower lid entropion
- Tea tree oil for Demodex blepharitis
- Topical immunosuppressants for blepharitis in adults
- Oral antibiotics for chronic blepharitis
- Types of materials for frontalis sling surgery for congenital ptosis
- Other (1)
- Refractive error (17)
- Acupuncture for slowing the progression of myopia in children and adolescents
- Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
- Laser-assisted in-situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism
- Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia
- Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children
- Interventions to slow progression of myopia in children
- Interventions to slow the progression of short-sightedness in children
- Laser photocoagulation for choroidal neovascularisation in pathologic myopia
- Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia
- Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction
- Vision screening for correctable visual acuity deficits in school-age children and adolescents
- Interventions for unilateral and bilateral refractive amblyopia
- Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia
- Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia
- Silicone hydrogel versus hydrogel soft contact lenses for differences in patient-reported eye comfort and safety
- Interventions to increase time spent outdoors for preventing incidence and progression of myopia in children
- Wavefront excimer laser refractive surgery for adults with refractive errors
- Rehabilitation (6)
- Assistive technology for children and young people with low vision
- Low vision rehabilitation for better quality of life in visually impaired adults
- Optical reading aids for children and young people with low vision
- Orientation and mobility training for adults with low vision
- Reading aids for adults with low vision
- Telerehabilitation for people with low vision
- Retinal disease (including age-related macular degeneration) (70)
- Age-related macular degeneration (24)
- Aflibercept for neovascular age-related macular degeneration
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
- Surgery for cataracts in people with age-related macular degeneration
- Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
- Complement inhibitors for age-related macular degeneration
- Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
- Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration
- Radiotherapy for neovascular age-related macular degeneration
- Implantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degeneration
- Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration
- Artificial intelligence for diagnosing exudative age-related macular degeneration
- Laser photocoagulation for neovascular age-related macular degeneration
- Laser treatment of drusen to prevent progression to advanced age-related macular degeneration
- Macular translocation for neovascular age-related macular degeneration
- Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration
- Optical coherence tomography angiography for monitoring the treatment of neovascular age-related macular degeneration
- Photodynamic therapy for neovascular age-related macular degeneration
- Statins for age-related macular degeneration
- Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration
- Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
- Ginkgo biloba extract for age-related macular degeneration
- Photobiomodulation for non-exudative age-related macular degeneration
- Diabetic eye disease (17)
- Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
- Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
- Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
- Blood pressure control for diabetic retinopathy
- Different lasers and techniques for proliferative diabetic retinopathy
- Single herbal medicine for diabetic retinopathy
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
- Interventions to increase attendance for diabetic retinopathy screening
- Fenofibrate for diabetic retinopathy
- Laser photocoagulation for proliferative diabetic retinopathy
- Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
- Pain control during panretinal photocoagulation for diabetic retinopathy
- Real-world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Monotherapy laser photocoagulation for diabetic macular oedema
- Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema
- Intravitreal steroids for macular edema in diabetes
- Other (18)
- Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis
- Antibiotics versus no treatment for toxoplasma retinochoroiditis
- Blue-light filtering intraocular lenses (IOLs) for protecting macular health
- Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Interventions for prevention of giant retinal tear in the fellow eye
- Pars plana vitrectomy with internal limiting membrane flap versus pars plana vitrectomy with conventional internal limiting membrane peeling for large macular hole
- Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters
- Ocriplasmin for symptomatic vitreomacular adhesion
- Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery
- Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear
- Surgical interventions for lamellar macular holes
- Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
- Vitrectomy for idiopathic macular hole
- Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH)
- Face-down positioning or posturing after macular hole surgery
- Surgery for idiopathic epiretinal membrane
- Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery
- Retinal detachment (6)
- Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments
- Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
- Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
- Face-down positioning or posturing after pars plana vitrectomy for macula-involving rhegmatogenous retinal detachments
- Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments
- Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy
- Retinal vascular occlusion (5)
- Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
- Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
- Macular grid laser photocoagulation for branch retinal vein occlusion
- Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion
- Interventions for acute non-arteritic central retinal artery occlusion
- Retinopathy of prematury [See Cochrane Neonatal] (0)
- Age-related macular degeneration (24)
- Uveitis (7)
- Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis
- Types of intraocular lenses for cataract surgery in eyes with uveitis
- Corticosteroids as adjuvant therapy for ocular toxoplasmosis
- Corticosteroid implants for chronic non-infectious uveitis
- Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults
- Interventions for the management of CMV-associated anterior segment inflammation
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis